Lupus Research Alliance News
Data Finds Smoking Raises, Drinking Can Decrease Lupus Risk

Data from a long-term Black Women’s Health Study of 59,000 Black women found that cigarette smoking raised the risk for lupus, but not significantly compared with those who had never smoked.  In contrast, the incidence of lupus was significantly lower among Black women who drank moderately which was defined as greater or equal to four […] READ MORE

Our Grantees Lead Investigation of Microbiome in Lupus

Sept. 5, 2018 Our microbiome includes all of the trillions of microorganisms that live in and on us. A recent review article about key discoveries on the role of the microbiome in lupus includes two researchers funded by the Lupus Research Alliance who may have discovered how some of these microbial passengers promote lupus by […] READ MORE

Lupus Research Alliance: Disappointed but Undaunted by Anifrolumab Results

September 4, 2018 The Lupus Research Alliance is disappointed with the results announced by AstraZeneca and MedImmune of the clinical trial testing the investigational drug anifrolumab for moderate to severe systemic lupus erythematosus (SLE).  However, the knowledge gained from further analyzing these data will be invaluable in fully understanding the effects of anifrolumab and designing […] READ MORE

New York Jets Tackle Lupus at 2018 Kickoff Luncheon!

August 28, 2018 The Lupus Research Alliance was proud to take part in the NY Jets 2018 KickOff Luncheon that launched the upcoming season while gaining awareness for the worthwhile causes supported by the team. With the help of nearly 800 generous supporters, the luncheon raised over $750,000 to benefit the Lupus Research Alliance along […] READ MORE

Hearst Foundations Awards Grant to Lupus Research Alliance

August 22, 2018 The Lupus Research Alliance is proud to once again be awarded the Health Grant from the Hearst Foundations. In the amount of $150,000, the highly sought Health Grant will help support two promising investigators relatively new to lupus who were recently awarded our Novel Research Grants, Drs. Andrea Knight and Vipin Kumar. […] READ MORE

Hard Advocacy Work Pays Off for Lupus!

August 24, 2018 The U.S. Senate voted 85 to 7 to approve the $2 billion budget increase Lupus Research Alliance advocates requested for medical research funded by the National Institutes of Health (NIH). This increase of 5.4 percent would bring the budget for the NIH up to $39,084,000,000. Per today’s vote, the Labor, Health and […] READ MORE

CareFirst and Exagen Diagnostics Announce Evidence Development Agreement for AVISE® Lupus Diagnostic Test

August 20, 2018 Source: CareFirst BlueCross BlueShield Press Release CareFirst BlueCross BlueShield (CareFirst) and Exagen Diagnostics, Inc. (Exagen) today announced an agreement to collaborate to study the impact of Exagen’s proprietary AVISE Lupus test.  As part of the agreement, select CareFirst members will have access to the AVISE Lupus test to aid in the differential […] READ MORE

Potential Treatment for Sun Damage Discovered with LRA Funding

August 16, 2018 Exposure to the sun is hard on everyone’s skin, causing cells to die. But skin cells are much more vulnerable in people with lupus.  That reaction is called photosensitivity. A team of scientists led by Theresa Lu, MD, PhD, at Hospital for Special Surgery (HSS) in New York may have discovered why. […] READ MORE

Three Renowned Researchers Share Scientific Successes

Three outstanding presentations by researchers at the Philadelphia Lupus Research Alliance Advancing Lupus Care Through Research and Advocacy Conference are summarized here: Dr. Andrea Knight, Children’s Hospital of Philadelphia “Lupus in Children: Effects on the Developing Brain” Dr. Knight focused on the effects of brain inflammation that occurs in at about 25% of kids with […] READ MORE

Inflammation Trigger Discovery May Lead to New Treatment

August 2, 2018 Inflammation helps us repair injuries and defeat infections. It’s supposed to shut down once a crisis is over. In people with lupus, however, inflammation persists and can damage the joints, skin, and organs. Researchers have discovered a molecular sensor in cells known as the NLRP3 inflammasome that triggers inflammation. When the inflammasome […] READ MORE

Learn and connect with our community!